InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
| Product | Citation | Year | Journal | Authors | Page |
|---|---|---|---|---|---|
| Recombinant anti-mouse IL-1β antibody | Symbiotic Firmicutes establish mutualism with the host via innate tolerance a... | 2023 | Cell Host Microbe | Jordan C.K.I. et al. | DOI: 10.1016/j.chom.2023.07.008 |
| Quil-A® adjuvant | Optimization of an alum-anchored clinical HIV vaccine candidate. | 2023 | NPJ Vaccines | Rodrigues K.A. et al. | DOI: 10.1038/s41541-023-00711-0 |
| Alhydrogel® adjuvant 2% | Optimization of an alum-anchored clinical HIV vaccine candidate. | 2023 | NPJ Vaccines | Rodrigues K.A. et al. | DOI: 10.1038/s41541-023-00711-0 |
| Pam3CSK4 | Detailed Mechanisms Underlying Neutrophil Bactericidal Activity against Strep... | 2023 | Biomedicines | Tsai Z. et al. | DOI: 10.3390/biomedicines11082252 |
| pFUSE-hIgG1-Fc | Chimeric antibody targeting unique epitope on onco-mucin16 reduces tumor burd... | 2023 | NPJ Precis Oncol. | Shah A. et al. | DOI: 10.1038/s41698-023-00423-7 |
| Normocin® - Antimicrobial Reagent | Evaluation of long-term immunity and protection against T. gondii after immun... | 2023 | Sci Rep. | Chyb M. et al. | DOI: 10.1038/s41598-023-40147-z |
| AddaVax™ | Evaluation of long-term immunity and protection against T. gondii after immun... | 2023 | Sci Rep. | Chyb M. et al. | DOI: 10.1038/s41598-023-40147-z |
| THP1-Blue™ NF-κB Cells | Evaluation of long-term immunity and protection against T. gondii after immun... | 2023 | Sci Rep. | Chyb M. et al. | DOI: 10.1038/s41598-023-40147-z |
| QUANTI-Blue™ | Evaluation of long-term immunity and protection against T. gondii after immun... | 2023 | Sci Rep. | Chyb M. et al. | DOI: 10.1038/s41598-023-40147-z |
| Blasticidin | Evaluation of long-term immunity and protection against T. gondii after immun... | 2023 | Sci Rep. | Chyb M. et al. | DOI: 10.1038/s41598-023-40147-z |
| Human TLR2 HEK293 Reporter Cells (NF-κB and IL-8) | Nanostructured Microparticles Repolarize Macrophages and Induce Cell Death in... | 2023 | Pharmaceutics | Al-Fityan S. et al. | DOI: 10.3390/pharmaceutics15071895 |
| LPS-EK (LPS from E. coli K12) | Nanostructured Microparticles Repolarize Macrophages and Induce Cell Death in... | 2023 | Pharmaceutics | Al-Fityan S. et al. | DOI: 10.3390/pharmaceutics15071895 |
| Recombinant human IL-1β protein | Nanostructured Microparticles Repolarize Macrophages and Induce Cell Death in... | 2023 | Pharmaceutics | Al-Fityan S. et al. | DOI: 10.3390/pharmaceutics15071895 |
| IL-1α & IL-1β Reporter HEK 293 Cells | Nanostructured Microparticles Repolarize Macrophages and Induce Cell Death in... | 2023 | Pharmaceutics | Al-Fityan S. et al. | DOI: 10.3390/pharmaceutics15071895 |
| Poly(I:C) HMW | Nanostructured Microparticles Repolarize Macrophages and Induce Cell Death in... | 2023 | Pharmaceutics | Al-Fityan S. et al. | DOI: 10.3390/pharmaceutics15071895 |
| Human TLR2 Reporter HEK293 Cells (NF-κB) | Nanostructured Microparticles Repolarize Macrophages and Induce Cell Death in... | 2023 | Pharmaceutics | Al-Fityan S. et al. | DOI: 10.3390/pharmaceutics15071895 |
| Pam3CSK4 | Nanostructured Microparticles Repolarize Macrophages and Induce Cell Death in... | 2023 | Pharmaceutics | Al-Fityan S. et al. | DOI: 10.3390/pharmaceutics15071895 |
| FSL-1 | Nanostructured Microparticles Repolarize Macrophages and Induce Cell Death in... | 2023 | Pharmaceutics | Al-Fityan S. et al. | DOI: 10.3390/pharmaceutics15071895 |
| QUANTI-Blue™ | Nanostructured Microparticles Repolarize Macrophages and Induce Cell Death in... | 2023 | Pharmaceutics | Al-Fityan S. et al. | DOI: 10.3390/pharmaceutics15071895 |
| Zeocin® | A novel defined TLR3 agonist as an effective vaccine adjuvant. | 2023 | Front Immunol. | Ko K.H. et al. | DOI: 10.3389/fimmu.2023.1075291 |